200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 592-31-4

592-31-4

592-31-4 | N-Butylurea

CAS No: 592-31-4 Catalog No: AG0035DB MDL No:MFCD00007956

Product Description

Catalog Number:
AG0035DB
Chemical Name:
N-Butylurea
CAS Number:
592-31-4
Molecular Formula:
C5H12N2O
Molecular Weight:
116.1616
MDL Number:
MFCD00007956
IUPAC Name:
butylurea
InChI:
InChI=1S/C5H12N2O/c1-2-3-4-7-5(6)8/h2-4H2,1H3,(H3,6,7,8)
InChI Key:
CNWSQCLBDWYLAN-UHFFFAOYSA-N
SMILES:
CCCCNC(=O)N
EC Number:
209-748-4
UNII:
9CPL5NR15K
NSC Number:
2597

Properties

Complexity:
72.8  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
116.095g/mol
Formal Charge:
0
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
116.164g/mol
Monoisotopic Mass:
116.095g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
55.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.4  

Literature

Title Journal
Denaturation mechanism of BSA by urea derivatives: evidence for hydrogen-bonding mode from fluorescence tools. Journal of fluorescence 20110701
Novel synthesis of ureas: application of t-butylureas. Chemical & pharmaceutical bulletin 20100101
Potent and selective small molecule NS3 serine protease inhibitors of Hepatitis C virus with dichlorocyclopropylproline as P2 residue. Bioorganic & medicinal chemistry 20080215
Synthesis and biological evaluation of homoserine lactone derived ureas as antagonists of bacterial quorum sensing. Bioorganic & medicinal chemistry 20060715
Specific modification of peptide-bound citrulline residues. Analytical biochemistry 20060501
A quadruply hydrogen bonded heterocomplex displaying high-fidelity recognition. Journal of the American Chemical Society 20051228
A highly stable quadruply hydrogen-bonded heterocomplex useful for supramolecular polymer blends. Journal of the American Chemical Society 20050511
Preclinical studies of alkylureas as anti-HIV-1 contraceptive. Current pharmaceutical design 20050101
Chalcogens as terminal ligands to iron: synthesis and structure of complexes with Fe(III)-S and Fe(III)-Se motifs. Journal of the American Chemical Society 20040602
Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease. Bioorganic & medicinal chemistry 20031103
Inhibition of HIV-1 infection by alkylureas. AIDS (London, England) 19911201

© 2019 Angene International Limited. All rights Reserved.